SIRP-alpha improves kidney transplant match predictions by identifying high-risk recipients and enhancing personalized ...

HanchorBio Inc. (TPEx: 7827.TWO), a pioneer of immunotherapy biologics, is announcing its official listing on the Taipei Exchange (TPEx) Emerging Stock Board under the ticker symbol 7827.TWO and the ...

Explore the latest advancements in immunotherapies for T-cell lymphoma, addressing unique challenges and promising new ...

Liminatus merged with blank check company Iris Acquisition Corp. in April to create a newly combined company called Liminatus Pharma Inc.

This new article publication from Acta Pharmaceutica Sinica B, discusses the use of engineered platelet-derived exosomal ...

This new article publication from Acta Pharmaceutica Sinica B, discusses the use of engineered platelet-derived exosomal spheres for enhanced tumor penetration and extended circulation in melanoma ...

Novartis has also been developing sabatolimab in combination with Gilead Sciences’ CD47-targeted antibody magrolimab – another drug struggling to show efficacy – in a phase 2 trial involving ...

If you sized SANA small after the May post, the thesis is tracking; consider letting winners run while watching for pullbacks ...

AstraZeneca spinout Dizal Pharmaceuticals won an FDA accelerated approval for sunvozertinib for previously treated EGFR ex 20 ...